Skip to main content

A Colossal deal: $60M raised by Ben Lamm's latest startup

De-extinction startup Colossal Biosciences is about to turn six months old, and it has already raised $75 million. Its latest $60 million funding round attracted a head-turning roster of investors and is expected to help the company bring the woolly mammoth back from extinction, among other lofty goals.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.